<SEC-DOCUMENT>0000898432-25-000062.txt : 20250123
<SEC-HEADER>0000898432-25-000062.hdr.sgml : 20250123
<ACCEPTANCE-DATETIME>20250123174913
ACCESSION NUMBER:		0000898432-25-000062
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250123
DATE AS OF CHANGE:		20250123

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amneal Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001723128
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90473
		FILM NUMBER:		25551131

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		(908) 947-3120

	MAIL ADDRESS:	
		STREET 1:		400 CROSSING BOULEVARD
		STREET 2:		3RD FLOOR
		CITY:			BRIDGEWATER
		STATE:			NJ
		ZIP:			08807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Atlas Holdings, Inc.
		DATE OF NAME CHANGE:	20171117

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Patel Dipan
		CENTRAL INDEX KEY:			0001745437
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		C/O PATEL PTC, LLC
		STREET 2:		100 WEST LIBERTY STREET, 10TH FLOOR
		CITY:			RENO
		STATE:			NV
		ZIP:			89501
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<previousAccessionNumber>0001193125-18-214792</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001745437</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>3</amendmentNo>
<securitiesClassTitle>Class A Common Stock, par value $0.01</securitiesClassTitle>
<dateOfEvent>11/13/2024</dateOfEvent>
<previouslyFiledFlag>false</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0001723128</issuerCIK>
<issuerCUSIP>03168L105</issuerCUSIP>
<issuerName>Amneal Pharmaceuticals, Inc.</issuerName>
<address>
<com:street1>400 Crossing Blvd</com:street1>
<com:city>Bridgewater</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>08807</com:zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>Christine Krentz</personName>
<personPhoneNum>949-409-6700</personPhoneNum>
<personAddress>
<com:street1>4 Gatehall Drive</com:street1>
<com:city>Parsippany</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>07054-4513</com:zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0001745437</reportingPersonCIK>
<reportingPersonName>Patel Dipan</reportingPersonName>
<memberOfGroup>a</memberOfGroup>
<fundType>OO</fundType>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<soleVotingPower>23828992</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>23828992</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
<aggregateAmountOwned>23828992</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>7.7</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 309,884,000 shares of Class A Common Stock outstanding, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed on November 11, 2024.</commentContent>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Class A Common Stock, par value $0.01</securityTitle>
<issuerName>Amneal Pharmaceuticals, Inc.</issuerName>
<issuerPrincipalAddress>
<com:street1>400 Crossing Blvd</com:street1>
<com:city>Bridgewater</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>08807</com:zipCode>
</issuerPrincipalAddress>
</item1>
<item4>
<transactionPurpose>The disclosure in Item 4 is hereby amended and supplemented by adding the following:&#13;
Between July 15 and November 13, 2024, trusts controlled by the Reporting Person sold 3,076,081 shares of Class A Common Stock in open market transactions at prices per share between $6.75 and $9.31.</transactionPurpose>
</item4>
<item5>
<numberOfShares>The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 309,884,000 shares of Class A Common Stock outstanding, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed on November 11, 2024:	 &#13;
 	  	 &#13;
Reporting Person - Dipan Patel&#13;
Amount beneficially owned - 23,828,992&#13;
Percent of class - 7.7&#13;
Sole power to vote or to direct the vote - 23,828,992&#13;
Shared power to vote or to direct the vote - 0&#13;
Sole power to dispose or to direct the disposition - 23,828,992&#13;
Shared power to dispose or to direct the disposition - 0&#13;
&#13;
The Reporting Person may be deemed to beneficially own 23,828,992 shares of Class A Common Stock held of record by trusts controlled by the Reporting Person.</numberOfShares>
<transactionDesc>The information set forth in Item 4 of this Amendment No. 3 is incorporated by reference herein.</transactionDesc>
<listOfShareholders>None.</listOfShareholders>
<date5PercentOwnership>Not applicable.</date5PercentOwnership>
</item5>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>Patel Dipan</signatureReportingPerson>
<signatureDetails>
<signature>Dipan Patel</signature>
<title>Dipan Patel</title>
<date>01/23/2025</date>
</signatureDetails>
</signaturePerson>
</signatureInfo>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
